7FU6

Crystal Structure of human cyclic GMP-AMP synthase in complex with 2-benzyl-6-(2-chloro-4-methylphenyl)indazole-4-carboxylic acid

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2019-03-04
Detector	PSI PILATUS 6M
Wavelength(s)	1.00003
Spacegroup name	P 21 21 2
Unit cell lengths	162.550, 44.830, 59.000
Unit cell angles	90.00, 90.00, 90.00

Refinement procedure

Resolution	81.280 - 2.370
R-factor	0.234
Rwork	0.233
R-free	0.26300
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.010
RMSD bond angle	1.150
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	BUSTER (2.11.7)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	81.270	81.280	2.430
High resolution limit [Å]	2.370	10.600	2.370
Rmerge	0.041	0.018	2.881
Rmeas	0.045	0.020	3.116
Total number of observations	118579
Number of reflections	18265	255	1281
<I/σ(I)>	17.53	61.55	0.44
Completeness [%]	99.9	98.1	99.6
Redundancy	6.492	4.784	6.845
CC(1/2)	1.000	1.000	0.280

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7	293	10-12 mg/mL protein in 25 mM Tris/HCl pH7.5, 500mM NaCl, 2mM TCEP, supplemented with 10x molar excess of ligand and, if needed, with 10 mM MgCl2 and 5mM ATP, then mixed 1:1 with reservoir of the Procomplex screen. Several conditions resulted in crystals